Ignite Creation Date:
2024-05-06 @ 8:16 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06318897
Status:
RECRUITING
Last Update Posted:
2024-05-31
First Post:
2024-03-13
Brief Title:
Open-label Single Center Single-arm Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer
Sponsor:
Organization:
MD Anderson Cancer Center